ARKG vs. ARKD
ARKG (ARK Genomic Revolution Multi-Sector ETF) and ARKD (ARK 21Shares Digital Asset and Blockchain Strategy ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while ARKD is a Cryptocurrency fund actively managed by ARK. Both are actively managed. Their correlation of 0.81 suggests significant overlap in exposure. ARKG charges 0.75%/yr vs 0.90%/yr for ARKD.
Performance
ARKG vs. ARKD - Performance Comparison
Loading charts...
Returns By Period
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
ARKD
- 1D
- -1.44%
- 1M
- -0.46%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG vs. ARKD - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 16.24% |
ARKD ARK 21Shares Digital Asset and Blockchain Strategy ETF | -2.04% |
Correlation
The correlation between ARKG and ARKD is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jan 5, 2026 | 0.81 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. ARKD — Risk / Return Rank
ARKG
ARKD
ARKG vs. ARKD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Digital Asset and Blockchain Strategy ETF (ARKD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | ARKD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | — | — |
| Martin ratioReturn relative to average drawdown | 4.67 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | ARKD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | -0.25 | +0.38 |
Drawdowns
ARKG vs. ARKD - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKD's maximum drawdown of -14.03%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKD.
Loading charts...
Drawdown Indicators
| ARKG | ARKD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -14.03% | -69.56% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -69.65% | -4.51% | -65.14% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -6.21% | -29.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | — | — |
Volatility
ARKG vs. ARKD - Volatility Comparison
Loading charts...
Volatility by Period
| ARKG | ARKD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 19.81% | +21.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 19.81% | +25.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 19.81% | +21.31% |
ARKG vs. ARKD - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is lower than ARKD's 0.90% expense ratio.
Dividends
ARKG vs. ARKD - Dividend Comparison
Neither ARKG nor ARKD has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKD ARK 21Shares Digital Asset and Blockchain Strategy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKG and ARKD have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ARKG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ARKG is cheaper with a 0.75% expense ratio, compared with 0.90% for ARKD.
ARKG and ARKD have nearly identical dividend yields, around 0.00%.
ARKG is categorized as Health & Biotech Equities, while ARKD is Cryptocurrency. Their fees differ too: 0.75% for ARKG and 0.90% for ARKD.
Find the right allocation for ARKG and ARKD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer